Over-the-Counter Diagnostic Products World MarketsTriMark PublicationsOctober 1, 2012 398 Pages - SKU: TRI2385930 |
|
Analysis of the Global In Vitro Diagnostics Market
5/2/2013 | published by: Frost & Sullivan
Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of the global pharmaceutical industry. This research deliverable leverages primary research, secondary sources, and Frost & Sullivan’s
|
read more...
|
$6,000.00
|
|
Critical Care Market to 2019 - Growth from Factor Concentrates New Indications and Increasing Demand for Albumin in Asia-Pacific
5/14/2013 | published by: GBI Research
Critical Care Market to 2019 - Growth from Factor Concentrates New Indications and Increasing Demand for Albumin in Asia-Pacific Summary GBI Research, the leading business intelligence provider, has released its latest research, “Critical Care Market to 2019
|
read more...
|
$3,500.00
|
|
The U.S. Market for Urgent Care Centers
3/22/2013 | published by: Kalorama Information
Urgent care centers in the United States provide an increasingly important option between a physician’s office and a hospital emergency room. They provide walk-in, extended hour access for acute illness and injury care
|
read more...
|
$2,500.00
|
|
Retail Clinics: Consumer Attitudes Results of the 2013 Kalorama Survey
3/22/2013 | published by: Kalorama Information
Retail Clinics: Consumer Attitudes Results of the 2013 Kalorama Survey - Retail clinics are medical settings located in a retail store. They are not free standing and do not offer all medical services.
|
read more...
|
$995.00
|
|
2013 Analysis of the US Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
4/22/2013 | published by: Venture Planning Group
Highlights Comprehensive 620-page analysis of the US tumor marker testing market. Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next
|
read more...
|
$9,700.00
|
|
2013 Analysis of the European Tumor Marker Testing Market: France, Germany, Italy, Spain, UK Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
4/18/2013 | published by: Venture Planning Group
This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test.This comprehensive five-country report identifies and evaluates major business opportunities emerging in the cancer diagnostics
|
read more...
|
$19,700.00
|
|
2013 Analysis of the German Nucleic Acid Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
4/22/2013 | published by: Venture Planning Group
Highlights Comprehensive 850-page market segmentation analysis of the German NAT market. Major issues pertaining to the German NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the
|
read more...
|
$6,700.00
|
|
2013 Analysis of the Italian Nucleic Acid Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
4/22/2013 | published by: Venture Planning Group
Highlights Comprehensive 850-page market segmentation analysis of the Italian NAT market. Major issues pertaining to the Italian NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the
|
read more...
|
$6,700.00
|
|
2013 Analysis of the UK Nucleic Acid Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
4/22/2013 | published by: Venture Planning Group
Highlights Comprehensive 855-page market segmentation analysis of the UK NAT market. Major issues pertaining to the UK NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the
|
read more...
|
$6,700.00
|
|
2013 Analysis of the European Nucleic Acid Testing Market: France, Germany, Italy, Spain, UK Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
4/18/2013 | published by: Venture Planning Group
This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. The report explores business
|
read more...
|
$19,700.00
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
General In Vitro Diagnostics Reports
- 2013 Analysis of the US Nucleic Acid Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
- 2013 Analysis of the UK Nucleic Acid Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
- 2013 Analysis of the Spanish Nucleic Acid Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
- 2013 Analysis of the Italian Nucleic Acid Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
- 2013 Analysis of the German Nucleic Acid Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape